Education
About Us
Working with TipRanks
Follow Us
Yubo International Biotech Limited. (YBGJ)
:YBGJ
Total Valuation
Yubo International Biotech has a market cap or net worth of $2.54M. The enterprise value is ―.
Market Cap$2.54M
Enterprise Value―
Share Statistics
Yubo International Biotech has 170,416,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding170,416,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Yubo International Biotech’s return on equity (ROE) is 2.13 and return on invested capital (ROIC) is -535.25%.
Return on Equity (ROE)2.13
Return on Assets (ROA)-0.51
Return on Invested Capital (ROIC)-535.25%
Return on Capital Employed (ROCE)6.89
Revenue Per Employee5.79K
Profits Per Employee-66.94K
Employee Count18
Asset Turnover0.04
Inventory Turnover0.16
Valuation Ratios
The current PE Ratio of Yubo International Biotech is ―. Yubo International Biotech’s PEG ratio is 0.41.
PE Ratio―
PS Ratio108.15
PB Ratio-19.95
Price to Fair Value-19.95
Price to FCF396.28
Price to Operating Cash Flow23.66
PEG Ratio0.41
Income Statement
In the last 12 months, Yubo International Biotech had revenue of 104.28K and earned -1.20M in profits. Earnings per share was -0.01.
Revenue104.28K
Gross Profit52.65K
Operating Income-1.21M
Pretax Income-1.20M
Net Income-1.20M
EBITDA-1.18M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -150.70K and capital expenditures 0.00, giving a free cash flow of -150.70K billion.
Operating Cash Flow-150.70K
Free Cash Flow-150.70K
Free Cash Flow per Share>-0.01
Dividends & Yields
Yubo International Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-87.83%
50-Day Moving Average0.01
200-Day Moving Average0.05
Relative Strength Index (RSI)37.17
Average Volume (3m)1.32K
Important Dates
Yubo International Biotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Yubo International Biotech as a current ratio of 0.30, with Debt / Equity ratio of -139.82%
Current Ratio0.30
Quick Ratio0.17
Debt to Market Cap0.07
Net Debt to EBITDA-0.66
Interest Coverage Ratio-5.26K
Taxes
In the past 12 months, Yubo International Biotech has paid -229.00 in taxes.
Income Tax-229.00
Effective Tax Rate<0.01
Enterprise Valuation
Yubo International Biotech EV to EBITDA ratio is -10.23, with an EV/FCF ratio of 423.41.
EV to Sales115.56
EV to EBITDA-10.23
EV to Free Cash Flow423.41
EV to Operating Cash Flow176.61
Balance Sheet
Yubo International Biotech has $5.30K in cash and marketable securities with $560.61K in debt, giving a net cash position of -$555.31K billion.
Cash & Marketable Securities$5.30K
Total Debt$560.61K
Net Cash-$555.31K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 50.49%, with operating margin of -1155.72%, and net profit margin of -1155.28%.
Gross Margin50.49%
Operating Margin-1155.72%
Pretax Margin-1155.50%
Net Profit Margin-1155.28%
EBITDA Margin-1129.32%
EBIT Margin0.00%
Analyst Forecast
The average price target for Yubo International Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―